Page 138 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

114 F. David Carmona, Ana Márquez, Javier Martín et al.

[108] Kariyazono, H., Ohno, T., Khajoee, V., et al. Association of vascular endothelial
growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery
lesions of Kawasaki disease. Pediatr. Res. 2004; 56:953-959.

[109] Onoyama, S., Ihara, K., Yamaguchi, Y., et al. Genetic susceptibility to Kawasaki
disease: analysis of pattern recognition receptor genes. Hum. Immunol. 2012; 73:654-
660.

[110] Park, J. A., Shin, K. S., Kim, Y. W. Polymorphism of matrix metalloproteinase-3
promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J.
Korean Med. Sci. 2005; 20:607-611.

[111] Onouchi, Y., Tamari, M., Takahashi, A., et al. A genomewide linkage analysis of
Kawasaki disease: evidence for linkage to chromosome 12. J. Hum. Genet. 2007; 52:
179-190.

[112] Onouchi, Y., Gunji, T., Burns, J. C., et al. ITPKC functional polymorphism associated
with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat.
Genet. 2008; 40:35-42.

[113] Onouchi, Y., Ozaki, K., Buns, J. C., et al. Common variants in CASP3 confer
susceptibility to Kawasaki disease. Hum. Mol. Genet. 2010; 19:2898-2906.

[114] Kuo, H. C., Yang, K. D., Juo, S. H., et al. ITPKC single nucleotide polymorphism
associated with the Kawasaki disease in a Taiwanese population. PloS One 2011; 6:
e17370.

[115] Kuo, H. C., Yu, H. R., Juo, S. H., et al. CASP3 gene single-nucleotide polymorphism
(rs72689236) and Kawasaki disease in Taiwanese children. J. Hum. Genet. 2011; 56:
161-165.

[116] Knight, A., Sandin, S., Askling, J. Risks and relative risks of Wegener's granulomatosis
among close relatives of patients with the disease. Arthritis Rheum. 2008; 58:302-307.

[117] Lyons, P. A., Rayner, T. F., Trivedi, S., et al. Genetically distinct subsets within
ANCA-associated vasculitis. N. Engl. J. Med. 2012; 367:214-223.

[118] Cotch, M. F., Fauci, A. S., Hoffman, G. S. HLA typing in patients with Wegener
granulomatosis. Ann. Intern. Med. 1995; 122:635.

[119] Papiha, S. S., Murty, G. E., Ad'Hia, A., et al. Association of Wegener's granulomatosis
with HLA antigens and other genetic markers. Ann. Rheum. Dis. 1992; 51:246-248.

[120] Spencer, S. J., Burns, A., Gaskin, G., et al. HLA class II specificities in vasculitis with
antibodies to neutrophil cytoplasmic antigens. Kidney Int. 1992; 41:1059-1063.

[121] Jagiello, P., Gencik, M., Arning, L., et al. New genomic region for Wegener's
granulomatosis as revealed by an extended association screen with 202 apoptosis-
related genes. Hum. Genet. 2004; 114:468-477.

[122] Heckmann, M., Holle, J. U., Arning, L., et al. The Wegener's granulomatosis
quantitative trait locus on chromosome 6p21.3 as characterized by tagSNP genotyping.
Ann. Rheum. Dis. 2008; 67:972-979.

[123] Stassen, P. M., Cohen-Tervaert, J. W., Lems, S. P., et al. HLA-DR4, DR13(6) and the
ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and
Wegener's granulomatosis. Rheumatology (Oxford) 2009; 48:622-625.

[124] Vaglio, A., Martorana, D., Maggiore, U., et al. HLA-DRB4 as a genetic risk factor for
Churg-Strauss syndrome. Arthritis Rheum. 2007; 56:3159-3166.

[125] Gencik, M., Meller, S., Borgmann, S., et al. Proteinase 3 gene polymorphisms and
Wegener's granulomatosis. Kidney Int. 2000; 58:2473-2477.

Complimentary Contributor Copy